Wolfgang W. Leitner

5.9k citations

82 papers · 4.7k indexed · 1 hit paper · h-index 27

Co-authors: Elke S. Bergmann‐Leitner Nicholas P. Restifo Stephan Frank Brigitte Gaume Richard J. Youle Everett G. Robert Frédéric Catez Carolyn L. Smith
Topics: Immunotherapy and Immune Responses (36 papers)vaccines and immunoinformatics approaches (15 papers)RNA Interference and Gene Delivery (12 papers)
Cited by: Immunology Virology Clinical Biochemistry
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States Austria United Kingdom

In The Last Decade

Wolfgang W. Leitner

81 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Dynamin-Related Protein 1, a Mediator of Mitochondrial Fission, in Apoptosis

2001 1.5k citations Elke S. Bergmann‐Leitner, Wolfgang W. Leitner et al. profile →

Peers

Countries citing papers authored by Wolfgang W. Leitner

Since Specialization

Citations

This map shows the geographic impact of Wolfgang W. Leitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang W. Leitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang W. Leitner more than expected).

Fields of papers citing papers by Wolfgang W. Leitner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang W. Leitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang W. Leitner. The network helps show where Wolfgang W. Leitner may publish in the future.

Co-authorship network of co-authors of Wolfgang W. Leitner

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang W. Leitner. A scholar is included among the top collaborators of Wolfgang W. Leitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang W. Leitner. Wolfgang W. Leitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings 2023 ·Human Vaccines & Immunotherapeutics ·(unknown),(unknown),Wolfgang W. Leitner	3
2	Optimizing the Immunogenicity of HIV Vaccines by Adjuvants – NIAID Workshop Report 2023 ·Vaccine ·Anjali Singh,César Boggiano,Michael A. Eller,Milton Maciel,Mary Marovich,Vijay Mehra,Annie X. Mo,Kentner L. Singleton,Wolfgang W. Leitner	2
3	Immunological consequences of arthropod vector‐derived salivary factors 2011 ·European Journal of Immunology ·Wolfgang W. Leitner,(unknown),(unknown)	17
4	Innate immunity in HIV infection and implications for vaccine design: A summary of the workshop held at the National Institute of Allergy and Infectious Diseases, Bethesda on February 25–26, 2010 2010 ·Vaccine ·Geetha P. Bansal,Wolfgang W. Leitner	1
5	Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis 2009 ·Vaccine ·Elke S. Bergmann‐Leitner,Wolfgang W. Leitner,Elizabeth H. Duncan,(unknown),Evelina Angov	16
6	Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines 2008 ·Gene Therapy ·Sandra S. Diebold,Oliver Schulz,Lena Alexopoulou,Wolfgang W. Leitner,Richard A. Flavell,Caetano Reis e Sousa	22
7	MFG-E8/Lactadherin Promotes Tumor Growth in an Angiogenesis-Dependent Transgenic Mouse Model of Multistage Carcinogenesis 2007 ·Cancer Research ·(unknown),Theresa Lopez,Feng Xu,Elke S. Bergmann‐Leitner,Wolfgang W. Leitner,Mark C. Udey	80
8	PRKAR1A Inactivation Leads to Increased Proliferation and Decreased Apoptosis in Human B Lymphocytes 2006 ·Cancer Research ·Audrey Robinson‐White,Wolfgang W. Leitner,Eiman Aleem,Philipp Kaldis,Ioannis Bossis,Constantine A. Stratakis	33
9	Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A☆☆☆ 2006 ·Vaccine ·Douglas S. Walsh,Montip Gettayacamin,Wolfgang W. Leitner,Jeffrey A. Lyon,Victoria Stewart,Gérald Marit,Sathit Pichyangkul,Panita Gosi,Pongsri Tongtawe,Kent E. Kester	22
10	Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization 2006 ·Journal of Allergy and Clinical Immunology ·(unknown),Sandra Scheiblhofer,(unknown),Wolfgang W. Leitner,(unknown),Cornelia Hauser‐Kronberger,Beate Alinger,(unknown),(unknown),Susanne Vrtala	21
11	Inhibition of type I allergic responses with nanogram doses of replicon‐based DNA vaccines 2006 ·Allergy ·Sandra Scheiblhofer,(unknown),Wolfgang W. Leitner,Renate Bauer,(unknown),Fátima Ferreira,Josef Thalhamer,Richard Weiss	17
12	Complement 3d: From molecular adjuvant to target of immune escape mechanisms 2006 ·Clinical Immunology ·Elke S. Bergmann‐Leitner,Wolfgang W. Leitner,George C. Tsokos	42
13	Myth, menace or medical blessing? The clinical potential and problems of genetic vaccines 2003 ·Expert Opinion on Biological Therapy ·Wolfgang W. Leitner	19
14	DNA vaccines and apoptosis: to kill or not to kill? 2003 ·Journal of Clinical Investigation ·Wolfgang W. Leitner,Nicholas P. Restifo	19
15	Normal Tissue Depresses While Tumor Tissue Enhances Human T Cell Responses In Vivo to a Novel Self/Tumor Melanoma Antigen, OA1 2003 ·The Journal of Immunology ·Christopher E. Touloukian,Wolfgang W. Leitner,Rhonda E. Schnur,Paul F. Robbins,Yong Li,Scott Southwood,Alessandro Sette,Steven A. Rosenberg,Nicholas P. Restifo	18
16	Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways 2002 ·Nature Medicine ·Wolfgang W. Leitner,Leroy N. Hwang,Michael DeVeer,Aimin Zhou,Robert H. Silverman,Bryan Williams,Thomas W. Dubensky,Ying Han,Nicholas P. Restifo	232
17	Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection 2001 ·European Journal of Immunology ·Sandra Scheiblhofer,Defeng Chen,Richard Weiss,Farhat A. Khan,Sven Mostböck,Konstantin Fegeding,Wolfgang W. Leitner,Josef Thalhamer,Jeffrey A. Lyon	37
18	Cancer therapy using a self-replicating RNA vaccine 1999 ·Nature Medicine ·Ying Han,Tal Zaks,Rong‐Fu Wang,Kari R. Irvine,Udai S. Kammula,Francesco M. Marincola,Wolfgang W. Leitner,Nicholas P. Restifo	269
19	Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites 1997 ·The Journal of Immunology ·Wolfgang W. Leitner,M C Seguin,W R Ballou,(unknown),(unknown),Michael J. Sheehy,Jeffrey A. Lyon	107
20	Immunoarchitecture and Specific Functions of Splenic Autotransplants at Different Implantation Sites 1992 ·European Surgical Research ·(unknown),Wolfgang W. Leitner,(unknown),(unknown),(unknown),Elke S. Bergmann‐Leitner,(unknown),(unknown)	17

About Wolfgang W. Leitner

Wolfgang W. Leitner is a scholar working on Immunology, Virology and Immunology and Allergy, having authored 82 papers that have together received 4.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (36 papers), vaccines and immunoinformatics approaches (15 papers) and RNA Interference and Gene Delivery (12 papers). The work is most often cited by research in Immunology (1.9k citations), Virology (196 citations) and Clinical Biochemistry (268 citations). Wolfgang W. Leitner has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Elke S. Bergmann‐Leitner, Nicholas P. Restifo, Stephan Frank, Brigitte Gaume, Richard J. Youle, Everett G. Robert, Frédéric Catez, Carolyn L. Smith, Ying Han and Leroy N. Hwang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact